Tisagenlecleucel Market to Expand Significantly as CAR-T Cell Therapy Advances Transform Cancer Treatment
The global Tisagenlecleucel Market is experiencing remarkable growth as the adoption of advanced cell and gene therapies continues to reshape cancer treatment. Tisagenlecleucel is a chimeric antigen receptor T-cell (CAR-T) therapy designed to treat specific blood cancers by genetically modifying a patient's own immune cells to recognize and destroy cancer cells. Growing investments in precision...
0 Σχόλια 0 Μοιράστηκε 149 Views 0 Προεπισκόπηση